Table 1 Baseline characteristics.
Characteristic | Overall, n = 7391 | Class A/Healthy, n = 1981 | Class B, n = 3261 | HFpEF, n = 451 | HFrEF, n = 1701 |
---|---|---|---|---|---|
Age | 64 (10) | 58 (8) | 65 (9)*† | 71 (8)* | 68 (10)* |
Sex | |||||
Female | 403 (55%) | 126 (64%) | 218 (67%) | 31 (69%) | 28 (16%)† |
Male | 336 (45%) | 72 (36%) | 108 (33%) | 14 (31%) | 142 (84%)† |
BMI | 27.2 (4.3) | 26.5 (3.8) | 27.2 (4.4)† | 29.3 (5.9)* | 27.5 (3.9)* |
LVEF | 61 (17) | 68 (8) | 67 (7) | 66 (8) | 28 (9)*† |
eGFR | 79 (25) | 86 (22) | 82 (26)*† | 73 (24)* | 63 (21)*† |
DM | 99 (13%) | 7 (3.5%) | 28 (8.6%)*† | 10 (22%)* | 54 (32%)*† |
Hypertension | 415 (56%) | 87 (44%) | 210 (64%)* | 31 (69%)* | 87 (51%)*† |
Dyslipidaemia | 131 (18%) | 8 (4%) | 24 (7.4%)† | 7 (16%)* | 92 (54%)*† |
AF | 68 (9.2%) | 2 (1%) | 7 (2.1%) | 2 (4.4%)* | 57 (34%)*† |
ARB | 236 (32%) | 12 (6.1%) | 50 (15%)* | 9 (20%)* | 165 (97%)*† |
Diuretics | 246 (33%) | 21 (11%) | 62 (19%)* | 14 (31%)* | 149 (88%)*† |
Beta-blockers | 237 (32%) | 18 (9.1%) | 53 (16%)* | 14 (31%)* | 152 (90%)*† |
MRA | 124 (17%) | 2 (1%) | 3 (0.9%) | 0 (0%) | 119 (70%)*† |
CCB | 220 (30%) | 15 (7.6%) | 35 (11%) | 6 (13%) | 164 (97%)*† |
Anticoagulants | 161 (22%) | 5 (2.5%) | 15 (4.6%) | 7 (16%)* | 134 (79%)*† |
Statins | 276 (37%) | 24 (12%) | 89 (27%)* | 18 (40%)* | 145 (80%)*† |